Back

Quantitative faecal immunochemical test for patients with high risk bowel symptoms: a prospective cohort study

2020-05-15 oncology Title + abstract only
View on medRxiv
Show abstract

ObjectivesTo evaluate whether quantitative measurement of faecal haemoglobin (f-Hb) using faecal immunochemical testing (FIT) can be used to rule out colorectal cancer (CRC) for patients who present to primary care with high risk symptoms defined by national guidelines for urgent referral for suspected cancer (NICE NG12). DesignProspective cohort study carried out between April 2017 and March 2019. Setting59 GP practices in London and 24 hospitals in England. ParticipantsSymptomatic patients...

Predicted journal destinations